[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.5.76. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,638
Citations 0
Correction
December 1, 2015

Incorrect Nonproprietary Drug Name and Approved Use

JAMA. 2015;314(21):2308. doi:10.1001/jama.2015.15929

In the Original Investigation entitled “Cannabinoids for Medical Use: A Systematic Review and Meta-analysis,”1 published in the June 23/30, 2015, issue of JAMA, a nonproprietary name and use for a drug were incorrectly reported. In the first entry for Table 1, the parenthetical nonproprietary name for ajulemic acid should read “(JBT-101, CT3).” In this same row of the Table, the US legal status and approved use for this drug should read “Not currently in clinical use.” This article was corrected online. This article was also corrected in June 2015 for an error in Figure 4 and in July 2015 for an error in the abstract.2,3

References
1.
Whiting  PF, Wolff  RF, Deshpande  S,  et al.  Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456-2473.
PubMedArticle
2.
 Incorrect figure label [correction]. JAMA. 2015;314(5):520.Article
3.
 Incorrect values reported [correction]. JAMA. 2015;314(8):837.
×